Trials / Completed
CompletedNCT00215423
Study in Patients With COPD
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 49 (planned)
- Sponsor
- Dey · Industry
- Sex
- All
- Age
- 5 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine which dose of the investigational drug is the most safe and effective for the treatment of COPD compared to the control drug
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Formoterol Fumarate |
Timeline
- Primary completion
- 2003-12-01
- Completion
- 2005-09-01
- First posted
- 2005-09-22
- Last updated
- 2010-11-11
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT00215423. Inclusion in this directory is not an endorsement.